Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$318 Hold
14
﹤0.01% 628
2022
Q1
$376 Hold
14
﹤0.01% 899
2021
Q4
$223 Sell
14
-262
-95% -$4.21K ﹤0.01% 834
2021
Q3
$4.59K Sell
276
-8,757
-97% -$166K ﹤0.01% 746
2021
Q2
$192K Buy
+9,033
New +$207K 0.04% 407
2018
Q4
Sell
-1
Closed -$30 675
2018
Q3
$30 Hold
1
﹤0.01% 656
2018
Q2
$25 Hold
1
﹤0.01% 662
2018
Q1
$23 Sell
1
-1,948
-100% -$52.3K ﹤0.01% 602
2017
Q4
$47K Buy
+1,949
New +$46.4K 0.01% 344

Other funds holding ATI

Exane Derivatives's ATI Position: Q2 2022 in Review

Exane Derivatives held its ATI (ATI) position steady in Q2 2022 at 14 shares worth $318. The position accounts for ﹤0.01% of the portfolio, ranked #628.

Exane Derivatives first reported a position in ATI in Q4 2017 and has held it in 9 quarters since. The position peaked at $192K in Q2 2021. 266 funds tracked by Wall St. Rank hold ATI as of Q2 2022.

  • Exane Derivatives held 14 shares of ATI worth $318 as of Q2 2022.
  • Exane Derivatives left its ATI share count unchanged in Q2 2022.
  • ATI made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #628 holding.
  • Exane Derivatives first reported a position in ATI in Q4 2017 and has held it in 9 quarters since.
  • Exane Derivatives's ATI position peaked at $192K in Q2 2021.
  • 266 funds tracked by Wall St. Rank held ATI as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.